Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Egg yolk is a natural product derived from hen eggs, often utilized as a dietary supplement or as a source for specific therapeutic components. It contains various bioactive compounds, including antibodies like Immunoglobulin Y (IgY) and Antisecretory Factor (AF). IgY antibodies, produced from hyperimmunized laying hens, are being investigated for their ability to neutralize specific pathogens or proteins, such as gluten in celiac disease and Helicobacter Pylori. Antisecretory Factor (AF), a 41 kDa protein, is studied for its anti-secretory and anti-inflammatory effects, including modulating cytokine release, reducing intracranial pressure, and affecting ionic pumps. Products like Salovum (an AF-enriched egg yolk powder) and AGY (IgY in capsule form) are examples of formulations derived from egg yolk for therapeutic applications. Egg yolk is also studied for its nutritional impact on conditions like metabolic syndrome, cognitive function, and muscle health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Egg yolk.